|
CRBU | Caribou Biosciences, Inc. |
|
|
CRBU | Caribou Biosciences, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 1.00 |
| Leverage | 27.25% |
| Market Cap | $ 141.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -156.8m |
| Margin | -1801.69% |
None